During an assessment of Dialysis services
We carried out an assessment of dialysis services at DaVita UK Ltd – North Poole on 8 June 2026.
DaVita UK provides kidney care services to more than 250,000 patients across more than 3,000 clinics in 14 countries. There are currently 25 clinics in England and Wales.
The DaVita clinic in Poole has 27 dialysis stations including 3 side rooms. The clinic offers services on 6 days each week including morning, afternoon and evening sessions. . Patients are referred to the clinic by a local NHS hospital trust who commission the service. DaVita is registered with CQC to provide treatment of disease, disorder or injury.
We assessed all quality statements across safe, effective, caring, responsive and well-led key questions. We spoke with 8 patients, 7 staff and the registered manager for the service. We looked at 5 patient records.
We rated the service as requires improvement. We found a breach of regulation in relation to the safe management of medicines. This was a repeated breach from the last assessment of the service on 24 March 2021. Medicines were administered in a way that was unsafe and did not follow the organisation’s policy and or professional guidance. This increased the risk of patients receiving the wrong medicines. Following the assessment, we served a Warning Notice to the provider in relation to the safe management of medicines. The service has been told it must improve and be compliant with the regulations by 23 July 2026.
The service was proactive in learning from incidents. When things went wrong, the leadership team investigated concerns and learning was shared with staff. The service worked in partnership with other organisations to deliver, and improve, care. There were processes to maintain a safe environment and the provider took action to make improvements in response to shortfalls. Patients felt confident about staff’s ability to provide their care and treatment.
Although patient assessment records had some gaps, the service was committed to working with others to deliver effective care. Patient outcomes were monitored and patients were provided with advice and information about their health and wellbeing.
Staff were kind and caring and responded quickly to patients’ needs. Patients had choice and control over their treatment. The service listened to patients’ feedback and took action in response to their concerns. They communicated with patients about changes in the service and offered opportunities for patients to share ideas. Opportunities for further development included improving equity of experience and outcomes for patients with more complex needs by building staff’s confidence in providing this support.
Leadership and governance processes had failed to address concerns around medicines management identified at a previous CQC inspection 5 years ago. Although governance arrangements had not identified or managed risks in medicines administration, there were processes to promote the smooth running of the clinic. Workplace culture was an important part of the organisation’s strategy. Staff could raise concerns and felt confident they would be listened to. There were arrangements to promote an inclusive workplace, work in partnership with other organisations and participate in professional networks. This ensured the service had opportunities to learn from others and develop services which met patients’ needs, both now and in the future.
In instances where CQC has begun a process of regulatory action, we may publish this information on our website after any representations and/or appeals have been concluded, if the action has been taken forward.